Biotia

Biotia, a health tech company spun out of Cornell Tech, is dedicated to leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery. The company's core mission is to detect, predict, mitigate, and contain outbreaks before they escalate into pandemics. Biotia offers products like GeoSeeq, which enhances local labs in diagnostic deserts with advanced sequencing technology and training, and BIOTIA-DX, a clinically validated metagenomics tool that combines the accuracy of culture with heightened sensitivity.

Notable affiliates include researchers from Cornell Tech, who contribute to the company's innovative approach. Biotia has secured investments from prominent venture capital firms specializing in health tech. Key achievements include the successful deployment of their technology in various global regions, significantly improving outbreak detection and response times. Overall, Biotia's impact lies in its ability to fortify local diagnostic capabilities and provide rapid, accurate infectious disease identification, thereby enhancing global health security.